Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Diagnostics, Diatech Reach Distribution Deal for Molecular Reference Standards

NEW YORK (GenomeWeb News) – Diatech Pharmacogenetics will exclusively distribute Horizon Diagnostics' molecular reference standards under an agreement announced today.

As part of the deal announced by Horizon Diagnostics, a division of Horizon Discovery, Diatech will be the sole distributor of the molecular reference standards in Italy, San Marino, and Vatican City.

According to UK-based Horizon Diagnostics, the availability of validated reference materials will provide an industry standard for the development and quality control of molecular assays and improve their accuracy. Its molecular reference standards include FFPE cell line blocks, purified gDNA, and the recently released Quantitative Multiplex DNA Reference Standard for the assessment of multiple biomarkers in a single assay using platforms such as next-generation sequencing.

Financial and other terms of the deal were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.